- Investing Ideas
- /
- New Zealand Pharmaceuticals & Biotech Strong Balance Sheet Stocks
New Zealand Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
3
0 new
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
3 companies
AFT Pharmaceuticals
Market Cap: NZ$288.4m
Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.70
7D
7.1%
1Y
-12.9%
BLIS Technologies
Market Cap: NZ$19.2m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.
BLT
NZ$0.015
7D
7.1%
1Y
-16.7%
Pacific Edge
Market Cap: NZ$100.7m
A cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally.
PEB
NZ$0.13
7D
-0.8%
1Y
52.9%